Eulogy for a Quality Measure
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
On May 8, 2007, one of the best-known quality measures in health care was put to rest. The percentage of patients with acute myocardial infarction who receive a prescription for beta-blockers within 7 days of hospital discharge has been used to evaluate U.S. managed care plans since 1996. This measure will no longer be reported by the National Committee for Quality Assurance (NCQA) because it is simply no longer needed — a development that offers encouragement and important lessons.The data in the graph show why the NCQA Committee on Performance Measurement voted unanimously to retire the beta-blocker measure. A decade . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Traditionally, journal articles, workshops, academic classes, and conferences have been the usual mode of educating practitioners. Patient education and financial incentives have also been used, with all methods showing small to modest effects [6,70].”
From Translating research into everyday clinical practice: Lessons learned from a USA dental practice-based research network (2013) · cites this paper as [70]
Citations
Cites
Gottlieb, S. S., McCarter, R. J., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 982
Public Reporting and Pay for Performance in Hospital Quality Improvement
Lindenauer, P. K., Remus, D., Roman, S., Rothberg, M. B., Benjamin, E. M., Ma, A., & Bratzler, D. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064964 · Cited by 854
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
(1982) · JAMA · doi:10.1001/jama.247.12.1707 · Cited by 291
Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?
Lamas, G. A., Pfeffer, M. A., Hamm, P., Wertheimer, J., Rouleau, J.-L., & Braunwald, E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270405 · Cited by 227
Burwen, D. R., Galusha, D. H., Lewis, J. M., Bedinger, M. R., Radford, M. J., Krumholz, H. M., & Foody, J. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1430 · Cited by 111
Cited by
Items 101–134 of 134
Beta-Blocker Therapy After Myocardial Infarction
Taqueti, V. R., & O’Gara, P. T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.007 · Cited by 4
“Their routine use in this setting became so well established that a hospital performance measure, the percentage of patients with acute MI prescribed beta-blockers within 7 days of hospital discharge, was retired in 2007 by the National Committee for Quality Assurance after documented success rates beyond 90% (1).”
BackgroundThe Evolution of Heart Failure Therapy in the Past Sixty Years: One Man's Journey
Goldstein, S. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.06.005 · Cited by 3
“It required the quality care initiatives of the National Committee for Quality Assurance and the advocacy of beta-blocker therapy in the guidelines developed by the American College of Cardiology and the American Heart Association in 1996 for beta-blocker therapy to become the standard treatment in all patients with a…”
MethodInfluentialAiming for Ideal Care: A Proposed Framework for Cancer Quality Improvement
McNiff, K. K., & Jacobson, J. O. (2014) · Journal of Oncology Practice · doi:10.1200/jop.2014.001305 · Cited by 3
“Up to 25 years have been required to translate strong evidence into reliably delivered care (for example, routine use of beta blockers after myocardial infarction).(22) The difference between care that should be provided on the basis of strong foundations of efficacy and effectiveness, and that which is routinely prov…”
BackgroundComparative Effectiveness Evaluation as Outcomes Research
Bae, J. (2012) · Journal of the Korean Society of Hypertension · doi:10.5646/jksh.2012.18.1.24 · Cited by 3
Issues in access to end-of-life care in low-resource areas
Jain, Y. K., & Phutke, G. (2017) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2017.091 · Cited by 4
Appropriateness of Otic Quinolone Use among Privately Insured US Patients
Tran, P. T., Winterstein, A. G., Wang, X., Rhew, K., & Antonelli, P. J. (2019) · Otolaryngology · doi:10.1177/0194599819889607 · Cited by 3
Gill, G. S., Latif, A., Hilleman, D. E., Lavie, C. J., & Alla, V. M. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100878 · Cited by 4
Surgeons Attitude toward Psychosocial Aspects of Trapeziometacarpal Osteoarthritis
Ottenhoff, J. S. E., Ring, D., van der Molen, A. B. M., Coert, J. H., & Teunis, T. (2022) · Journal of Hand and Microsurgery · doi:10.1055/s-0042-1748879 · Cited by 3
Ke, J. X. C., Sparrow, K., Smith, M. A., Yoo, K. M., Yee, M.-S., Sun, L. Y., Beattie, W. S., Lim, E., & Görges, M. (2025) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-025-02943-1 · Cited by 3
Using research to make health care safer
Jorm, C. M., & White, S. J. (2009) · Australian Health Review · doi:10.1071/ah090400 · Cited by 4
Outcomes research: science and action
Ting, H. H., Xiang, M.-X., & Wang, J.-A. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.bqicc705 · Cited by 2
“…2013 14(8):659-663 662 discovery that β-blockers improve survival after myocardial infarction in the β-Blocker Heart Attack Trial (BHAT) to achieve the performance standard that 90% of patients after acute myocardial infarction are discharged from the hospital on a β-blocker (Lee, 2007).”
BackgroundOsude, N., Spall, H. G. C. V., Bosworth, H. B., Krychtiuk, K. A., Spertus, J. A., Fatoba, S., Fleisher, L., Fry, E. T. A., Green, J., Greene, S. J., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.03.005 · Cited by 2
Loss function-based evaluation of physician report cards
de la Guardia, F. H., Hwang, J., Adams, J., & Paddock, S. M. (2018) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-018-0179-2 · Cited by 2
“Some measures, particularly ones that have been monitored for several years (Lee 2007), can have very high average performance.”
BackgroundHeller, F. (2008) · Acta Clinica Belgica · doi:10.1179/acb.2008.63.2.002 · Cited by 2
“De même, malgré un bénéfi ce clinique évident, l’utilisation d’aspirine et de médicaments bloquant les canaux calciques chez les patients ayant eu un infarctus du myocarde, n’a progressé que lentement aux EtatsUnis (32).”
BackgroundEducación Médica Continua (EMC)
Sepúlveda, J. D. (2007) · ARS MEDICA Revista de Ciencias Médicas · doi:10.11565/arsmed.v36i2.145 · Cited by 1
Implementation of Multiple Evidence-Based Heart Failure Therapies
Latif, A., Ahsan, M. J., Lateef, N., Kapoor, V., Tran, A. M., Abusnina, W. A., Lundgren, S. W., Goldsweig, A. M., Ahsan, M. Z., & Mirza, M. M. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101293 · Cited by 1
Fragility fractures in older patients: reducing the risk
Tosi, L. L. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01695.x · Cited by 1
HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
Curtiss, F. R. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.3.316 · Cited by 1
Measurement and Improvement of Quality of Cardiovascular Care
Lee, T. H.-Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00005-6 · Cited by 1
Self-citationCoronary stent use in New York State in the drug‐eluting stent era
Qian, F., Hannan, E. L., Glance, L. G., Phelps, C. E., Ling, F. S. K., & Veazie, P. J. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01699.x
A relação entre eficiência e efectividade : aplicação ao internamento por doença cerebrovascular
Lopes, S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 7
Should β-Blockers Be Prescribed More Frequently to Japanese Patients With Coronary Artery Disease?
Imamura, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0236
Not Sold on Performance Measures
Landon, B. E., & Normand, S. T. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00020
Lilly, C. M., Zuckerman, I. H., Badawi, O., & Riker, R. R. (2011)
Beta Blockers, Calcium Channel Blockers, Ranolazine, Nitrates, and Nitric Oxide Donors
Commerford, P., & Opie, L. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-4927-2.00023-2
Moens, M., & van den Nieuwenhof, J. (2008)
The Role of Transparency in Patient Safety Improvement
Mello, M. M., Studdert, D. M., Nallamothu, B. K., & Kachalia, A. B. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108658867.022
Metodologia clinica oggi nel paziente internistico complesso
Nardi, G. E. R., Gnerre, P., Fontanella, A., & Manfellotto, D. (2020) · Italian Journal of Medicine · doi:10.4081/itjm.q.2020.1
배종면 (2012)
Ring, D. (2022) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000002205
(2012) · Pain Physician · doi:10.36076/ppj/2012
(2008) · Elsevier eBooks · doi:10.1016/b978-2-294-70451-2.50014-1
Characteristics and Financial Implications of Measures Removed From Medicare Advantage Star Ratings
Lake, D. T., Civelek, Y., Bond, A. M., & Khullar, D. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.40240
Metadata
- Authors
- Lee, T. H.
- Affiliations
- National Committee for Quality Assurance (US)
- Corresponding author
- Lee, Thomas H.
- ORCID
- Lee, Thomas H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-09-20
- Volume
- 357
- Issue
- 12
- Pages
- 1175-1177
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2020550871
- Cited by
- 135
- References
- 5
- Citations by year
- 2026: 1 · 2025: 3 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 9 · 2013: 5 · 2012: 11
- FWCI
- 36.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Quality and Management
- Health Sciences › Medicine › Family Practice › Primary Care and Health Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- acute myocardial infarction, quality metrics, managed care plans, National Committee for Quality Assurance, performance measurement, quality reporting, hospital discharge
- MeSH terms
- Adrenergic beta-Antagonists, Humans, Managed Care Programs, Myocardial Infarction, United States, Outcome Assessment, Health Care, Quality Indicators, Health Care, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.